Intravenous immunoglobulin in two children with Guillain-Barré syndrome
Notarangelo, L. D. ; Duse, M. ; Tiberti, S. ; Guarneri, B. ; Brunori, A. ; Negrini, A. ; Ugazio, A. G.
Springer
Published 1993
Springer
Published 1993
| ISSN: |
1432-1076
|
|---|---|
| Keywords: |
Guillain-Barrè syndrome ; Intravenous immunoglobulin
|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Medicine
|
| Notes: |
Abstract Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.
|
| Type of Medium: |
Electronic Resource
|
| URL: |
| _version_ | 1798295578583498753 |
|---|---|
| autor | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. |
| autorsonst | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. |
| book_url | http://dx.doi.org/10.1007/BF01956757 |
| datenlieferant | nat_lic_papers |
| hauptsatz | hsatz_simple |
| identnr | NLM205187927 |
| issn | 1432-1076 |
| journal_name | European journal of pediatrics |
| materialart | 1 |
| notes | Abstract Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome. |
| package_name | Springer |
| publikationsjahr_anzeige | 1993 |
| publikationsjahr_facette | 1993 |
| publikationsjahr_intervall | 8009:1990-1994 |
| publikationsjahr_sort | 1993 |
| publisher | Springer |
| reference | 152 (1993), S. 372-374 |
| schlagwort | Guillain-Barrè syndrome Intravenous immunoglobulin |
| search_space | articles |
| shingle_author_1 | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. |
| shingle_author_2 | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. |
| shingle_author_3 | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. |
| shingle_author_4 | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. |
| shingle_catch_all_1 | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. Intravenous immunoglobulin in two children with Guillain-Barré syndrome Guillain-Barrè syndrome Intravenous immunoglobulin Guillain-Barrè syndrome Intravenous immunoglobulin Abstract Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome. 1432-1076 14321076 Springer |
| shingle_catch_all_2 | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. Intravenous immunoglobulin in two children with Guillain-Barré syndrome Guillain-Barrè syndrome Intravenous immunoglobulin Guillain-Barrè syndrome Intravenous immunoglobulin Abstract Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome. 1432-1076 14321076 Springer |
| shingle_catch_all_3 | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. Intravenous immunoglobulin in two children with Guillain-Barré syndrome Guillain-Barrè syndrome Intravenous immunoglobulin Guillain-Barrè syndrome Intravenous immunoglobulin Abstract Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome. 1432-1076 14321076 Springer |
| shingle_catch_all_4 | Notarangelo, L. D. Duse, M. Tiberti, S. Guarneri, B. Brunori, A. Negrini, A. Ugazio, A. G. Intravenous immunoglobulin in two children with Guillain-Barré syndrome Guillain-Barrè syndrome Intravenous immunoglobulin Guillain-Barrè syndrome Intravenous immunoglobulin Abstract Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome. 1432-1076 14321076 Springer |
| shingle_title_1 | Intravenous immunoglobulin in two children with Guillain-Barré syndrome |
| shingle_title_2 | Intravenous immunoglobulin in two children with Guillain-Barré syndrome |
| shingle_title_3 | Intravenous immunoglobulin in two children with Guillain-Barré syndrome |
| shingle_title_4 | Intravenous immunoglobulin in two children with Guillain-Barré syndrome |
| sigel_instance_filter | dkfz geomar wilbert ipn albert fhp |
| source_archive | Springer Online Journal Archives 1860-2000 |
| timestamp | 2024-05-06T09:38:26.388Z |
| titel | Intravenous immunoglobulin in two children with Guillain-Barré syndrome |
| titel_suche | Intravenous immunoglobulin in two children with Guillain-Barré syndrome |
| topic | WW-YZ |
| uid | nat_lic_papers_NLM205187927 |